These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35256883)

  • 41. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study.
    Piekos SN; Roper RT; Hwang YM; Sorensen T; Price ND; Hood L; Hadlock JJ
    Lancet Digit Health; 2022 Feb; 4(2):e95-e104. PubMed ID: 35034863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
    Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
    Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Progress in the Diagnosis and Management of Type 2 Diabetes Mellitus in the Era of COVID-19 and Single Cell Multi-Omics Technologies.
    Kupai K; Várkonyi T; Török S; Gáti V; Czimmerer Z; Puskás LG; Szebeni GJ
    Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sequelae in children with severe SARS-CoV-2-related disease requiring Intensive Care: description and comparison with other reasons for admission].
    Leoz Gordillo I; García Remiro J; Barbero Peco C; Alonso Pérez A; García Salido A; González Brabin A; Cabrero Hernández M; Nieto Moro M
    Med Intensiva; 2022 Oct; 46(10):585-587. PubMed ID: 35017769
    [No Abstract]   [Full Text] [Related]  

  • 45. Insulin may promote SARS-CoV-2 cell entry and replication in diabetes patients.
    Sun W
    Med Hypotheses; 2023 Jan; 170():110997. PubMed ID: 36540082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection.
    Corcillo A; Saqib A; Sithamparanathan N; Khanam A; Williams J; Gulati A; Kariyawasam D; Karalliedde J
    Int J Endocrinol; 2022; 2022():8030765. PubMed ID: 35256883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection.
    Reștea PA; Mureșan M; Voicu A; Jurca T; Pallag A; Marian E; Vicaș LG; Jeican II; Crivii CB
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.
    Heald AH; Jenkins DA; Williams R; Sperrin M; Fachim H; Mudaliar RN; Syed A; Naseem A; Gibson JM; Bowden Davies KA; Peek N; Anderson SG; Peng Y; Ollier W
    Diabetes Ther; 2022 May; 13(5):1007-1021. PubMed ID: 35325361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection.
    Laurenzi A; Caretto A; Molinari C; Mercalli A; Melzi R; Nano R; Tresoldi C; Rovere Querini P; Ciceri F; Lampasona V; Bosi E; Scavini M; Piemonti L
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1009-e1019. PubMed ID: 34718627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study.
    Goyal A; Gupta Y; Kalaivani M; Bhatla N; Tandon N
    Diabetes Ther; 2021 Nov; 12(11):3011-3023. PubMed ID: 34611859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A practical guidance on the use of intravenous insulin infusion for management of inpatient hyperglycemia: Intravenous Insulin Infusion for Management of Inpatient Hyperglycemia.
    Goyal A; Mathew UE; Golla KK; Mannar V; Kubihal S; Gupta Y; Tandon N
    Diabetes Metab Syndr; 2021; 15(5):102244. PubMed ID: 34425556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 infection induces beta cell transdifferentiation.
    Tang X; Uhl S; Zhang T; Xue D; Li B; Vandana JJ; Acklin JA; Bonnycastle LL; Narisu N; Erdos MR; Bram Y; Chandar V; Chong ACN; Lacko LA; Min Z; Lim JK; Borczuk AC; Xiang J; Naji A; Collins FS; Evans T; Liu C; tenOever BR; Schwartz RE; Chen S
    Cell Metab; 2021 Aug; 33(8):1577-1591.e7. PubMed ID: 34081913
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.